<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: A genome-wide scan of gene expression in leucocytes in Asian Indians with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> was performed and correlated with their known phenotype </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Microarray gene profiling of 13,474 sequence-verified, non-redundant human cDNAs was done to study leukocyte gene expression in Asian Indians with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (DM: n=3) and matched controls (n=3) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Significant differential expression (fold change &lt;0.3 or &gt;3) was noted for 897 genes in DM vs. controls </plain></SENT>
<SENT sid="3" pm="."><plain>The 147 known genes in this category belonged to following broad functional groups (%): enzyme (32), nucleic acid binding (22), ligand binding or carrier (10), signal transducer (9), transporter (7), structural protein (6), cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> (3), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor (3), transcription factor binding (2), <z:chebi fb="0" ids="23924">enzyme inhibitor</z:chebi> (2), chaperone (2), cell cycle regulator (1), and defense/immunity protein (1) </plain></SENT>
<SENT sid="4" pm="."><plain>The 20 genes with at least a 3-fold change, annotated with known phenotypic associations in the current gene databank (phenotype association, fold change) were aspartoacylase (<z:e sem="disease" ids="C0206307" disease_type="Disease or Syndrome" abbrv="">Canavan disease</z:e>, 9.96), growth hormone receptor (Laron <z:hpo ids='HP_0003510'>dwarfism</z:hpo>, idiopathic <z:hpo ids='HP_0004322'>short stature</z:hpo>, 8.25), <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> lipase (familial <z:e sem="disease" ids="C1274228" disease_type="Disease or Syndrome" abbrv="">chylomicronemia syndrome</z:e>, <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> lipase deficiency, 8.00), <z:chebi fb="27" ids="27300">vitamin D</z:chebi> (1,25- dihydroxyvitamin D3) receptor (involutional <z:hpo ids='HP_0000939'>osteoporosis</z:hpo>, <z:chebi fb="27" ids="27300">vitamin D</z:chebi> resistant <z:hpo ids='HP_0002748'>rickets</z:hpo>, 7.94), intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule 1 human rhinovirus receptor (<z:e sem="disease" ids="C0024534" disease_type="Disease or Syndrome" abbrv="">cerebral malaria</z:e> susceptibility, 7.16), peroxisomal membrane protein 3 35-kDa (<z:e sem="disease" ids="C0282527" disease_type="Disease or Syndrome" abbrv="IRD">Refsum disease, infantile</z:e> form, <z:e sem="disease" ids="C0043459" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="ZS|ZWS">Zellweger syndrome</z:e>-3, 6.00), <z:e sem="disease" ids="C0752166" disease_type="Disease or Syndrome" abbrv="">Bardet-Biedl syndrome</z:e> 2 (<z:e sem="disease" ids="C0752166" disease_type="Disease or Syndrome" abbrv="">Bardet-Biedl syndrome</z:e>, 5.87), ribosomal protein S19 (Diamond Blackfan <z:hpo ids='HP_0001903'>anemia</z:hpo>, 5.85), <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> C-III (<z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo>, 5.44), argininosuccinate lyase (<z:e sem="disease" ids="C0268547" disease_type="Disease or Syndrome" abbrv="">argininosuccinicaciduria</z:e>, 5.22), myosin VA (Griscelli syndrome-type pigmentary dilution with <z:hpo ids='HP_0001249'>mental retardation</z:hpo>, 4.92), lysozyme (<z:hpo ids='HP_0001917'>renal amyloidosis</z:hpo>, 4.17), <z:chebi fb="75" ids="15414">SAM</z:chebi> domain, SH3 domain and nuclear localisation signals 1 (<z:e sem="disease" ids="C0008029" disease_type="Disease or Syndrome" abbrv="">Cherubism</z:e>, 4.12 ), <z:e sem="disease" ids="C0019562" disease_type="Disease or Syndrome" abbrv="">von Hippel-Lindau syndrome</z:e> (<z:hpo ids='HP_0010797'>hemangioblastoma</z:hpo>, cerebellar, somatic, <z:e sem="disease" ids="C0019562" disease_type="Disease or Syndrome" abbrv="">von Hippel-Lindau syndrome</z:e>, 3.94), early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0003002'>breast cancer</z:hpo> 1 (BRCA1, papillary serous <z:mp ids='MP_0002038'>carcinoma</z:mp> of the peritoneum, 3.73), <z:chebi fb="15" ids="17659">UDP</z:chebi>-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase (inclusion body <z:hpo ids='HP_0003198'>myopathy</z:hpo>, <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo>, <z:e sem="disease" ids="C0342853" disease_type="Disease or Syndrome" abbrv="">sialuria</z:e>, 3.53), <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A-I (<z:hpo ids='HP_0011034'>amyloidosis</z:hpo>, 3 or more types, <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e>, 3.29), midline 1 Opitz/BBB syndrome (<z:e sem="disease" ids="C1408833" disease_type="Disease or Syndrome" abbrv="">Opitz</z:e> <z:e sem="disease" ids="C0175696" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="OGS1|BBBG1">G syndrome</z:e>, type I, 3.28), ATPase, <z:chebi fb="1" ids="29101">Na+</z:chebi>/K+ transporting, alpha 2 (+) <z:chebi fb="1" ids="15841">polypeptide</z:chebi> (familial hemiplegic <z:hpo ids='HP_0002076'>migraine</z:hpo>, 3.05) </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0206307" disease_type="Disease or Syndrome" abbrv="">Canavan disease</z:e>, <z:e sem="disease" ids="C0043459" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="ZS|ZWS">Zellweger syndrome</z:e>, <z:e sem="disease" ids="C0282527" disease_type="Disease or Syndrome" abbrv="IRD">infantile Refsum disease</z:e>, Griscelli syndrome, <z:e sem="disease" ids="C0008029" disease_type="Disease or Syndrome" abbrv="">cherubism</z:e>, <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, peritoneal papillary serous <z:mp ids='MP_0002038'>carcinoma</z:mp>, <z:e sem="disease" ids="C1408833" disease_type="Disease or Syndrome" abbrv="">Opitz</z:e> G/<z:chebi fb="2" ids="33602">BBB</z:chebi> syndrome, and familial hemiplegic <z:hpo ids='HP_0002076'>migraine</z:hpo> (FHM) are phenotypes not previously reported in association with type 2 DM, but whose underlying genes were up-regulated in this peripheral genome scan of Asian Indians </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Rare and/or previously unknown phenotypes linked to known genes with significant differential expression in type 2 DM are reported </plain></SENT>
<SENT sid="7" pm="."><plain>Further testing of <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in <z:mp ids='MP_0002055'>diabetes</z:mp> phenotype syndromes may reveal common pathogenic mechanisms and potential candidate genes responsible for type 2 DM </plain></SENT>
</text></document>